Alpha Tau Medical (DRTS) Share-based Compensation (2021 - 2025)

Alpha Tau Medical (DRTS) has reported Share-based Compensation for 5 consecutive years, with $9.4 million the latest figure, recorded in Q4 2025.

• Quarterly Share-based Compensation fell 22.79% year-over-year to $9.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.4 million (down 22.79% YoY) and the FY2025 annual result came in at $10.6 million, down 12.36% from the prior year.
• Share-based Compensation retreated to $9.4 million in Q4 2025 per DRTS's latest filing, from $15.4 million in the prior quarter.
• Over the last five years, Share-based Compensation for DRTS reached as high as $19.5 million in Q2 2023 and fell as low as $145000.0 in Q1 2021.
• A 5-year average of $9.3 million and a median of $10.7 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation soared 1266.9% — and 2025, when it retreated 22.79%.
• Year by year, Share-based Compensation stood at $2.3 million in 2021, then tumbled by 35.83% to $1.5 million in 2022, then jumped by 884.01% to $14.4 million in 2023, then slipped by 15.85% to $12.1 million in 2024, then fell by 22.79% to $9.4 million in 2025.
• According to Business Quant data, Share-based Compensation over the past three periods registered $9.4 million, $15.4 million, and $12.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.